Recent Updates
Recently added Catalysts
VTRS Positive Sentiment Score: 75/100

Viatris to Present at the 43rd Annual J.P. Morgan Healthcare Conference Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced that the company will present at the 43rd Annual J.P. Morgan Healthcare...

Key Takeaway: Viatris Inc. (NASDAQ: VTRS) has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference, scheduled for January 14, 2025. The presentation will feature a fireside chat starting at 8:15 a.m. PT / 11:15 a.m. ET. Interested parties can access a live webcast and an archived version of the presentation on their investor website. Viatris aims to bridge the gap between generics and branded medicines to enhance global healthcare access.

Market Sentiment Analysis

POSITIVE FACTORS

  • Viatris will showcase its initiatives at a prominent healthcare conference.
  • The presentation is part of the company's strategy to enhance visibility and engagement.
  • Viatris is recognized for its extensive portfolio and global health impact.

Full Press Release Details

PITTSBURGH , Jan. 7, 2025 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS ), a global healthcare company, today announced that the company will present at the 43 rd Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 14, 2025 . The company's presentation and fireside chat will begin at 8:15 a.m. PT / 11:15 a.m. ET .
A live webcast of the event can be found at investor.viatris.com . An archived version of the presentation will be available following the live event and can be accessed at the same location for a limited time.
About Viatris Viatris Inc. (NASDAQ: VTRS ) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale, currently supplying high-quality medicines to approximately 1 billion patients around the world annually and touching all of life's moments, from birth to the end of life, acute conditions to chronic diseases. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world's most enduring health challenges, access takes on deep meaning at Viatris. We are headquartered in the U.S., with global centers in Pittsburgh , Shanghai and Hyderabad, India . Learn more at viatris.com and investor.viatris.com , and connect with us on LinkedIn , Instagram , YouTube and X (formerly Twitter).
SOURCE Viatris Inc.

21 %

About Viatris Inc.

Ticker Symbol: VTRS
Exchange: NASDAQ
Mission: Empower people worldwide to live healthier at every stage of life
Patient Reach: ~1 billion patients annually
Global Centers: Pittsburgh, Shanghai, Hyderabad

Frequently Asked Questions

When will Viatris present at the J.P. Morgan Healthcare Conference?

Viatris will present on January 14, 2025, at 8:15 a.m. PT / 11:15 a.m. ET.

Where can I watch the Viatris presentation live?

The live webcast is available at investor.viatris.com.

What does Viatris aim to achieve in healthcare?

Viatris aims to empower people globally to live healthier at every stage of life.

How does Viatris serve its patients?

Viatris supplies high-quality medicines to approximately 1 billion patients annually.

What is the mission of Viatris?

Viatris's mission is to provide broad access to healthcare at scale.

Last updated: Jan 7, 2025